Why is Metagenomi, Inc. ?
1
The company has declared Negative results for the last 5 consecutive quarters
- ROCE(HY) Lowest at -49.02%
- DEBT-EQUITY RATIO (HY) Highest at -73.29 %
- RAW MATERIAL COST(Y) Grown by 104.78% (YoY)
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -26.35%, its profits have fallen by -25.7%
3
Below par performance in long term as well as near term
- Along with generating -26.35% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Metagenomi, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Metagenomi, Inc.
-26.35%
-1.11
73.15%
S&P 500
22.99%
1.78
12.93%
Quality key factors
Factor
Value
Sales Growth (5y)
-24.95%
EBIT Growth (5y)
-11.86%
EBIT to Interest (avg)
-88.64
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.04
Sales to Capital Employed (avg)
0.19
Tax Ratio
6.50%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
48.59%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.31
EV to EBIT
1.09
EV to EBITDA
1.16
EV to Capital Employed
-27.50
EV to Sales
-4.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-54.59%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Movement
3What is working for the Company
NET PROFIT(HY)
Higher at USD -45.59 MM
-18What is not working for the Company
ROCE(HY)
Lowest at -49.02%
DEBT-EQUITY RATIO
(HY)
Highest at -73.29 %
RAW MATERIAL COST(Y)
Grown by 104.78% (YoY
NET SALES(Q)
Lowest at USD 1.25 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -1,867.95 %
Here's what is working for Metagenomi, Inc.
Net Profit
Higher at USD -45.59 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Here's what is not working for Metagenomi, Inc.
Net Sales
At USD 1.25 MM has Fallen at -69.76%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Debt-Equity Ratio
Highest at -73.29 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Net Sales
Lowest at USD 1.25 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Operating Profit Margin
Lowest at -1,867.95 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Raw Material Cost
Grown by 104.78% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






